Thanks Phaedrus - the stats are very instructive in potentially demonstrating the regulator’s blind spot. It’s an interesting angle.
Perhaps the numbers could be reproduced and framed in terms of a question to Dr. Klinker. I noticed a while back that he went straight from interning at the FDA while doing his PhD to a permanent role - yes he may have a lot of research experience, but if you pop that question and steer him towards a reality check, he might look at the numbers staring at him and start thinking about what institutional bias there might be. (I say that because I have the same worry about my son who’s gone straight from
fininishing his PhD to a pure research job.) The answer could be as simple or mundane as their adoption of the popular contempt towards a dodgy stem cell industry that has escaped regulatory scrutiny for a very long time. Sometimes it’s just useful to be able to look at things with different lenses.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-17542
-
-
- There are more pages in this discussion • 274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.250B |
Open | High | Low | Value | Volume |
$1.13 | $1.16 | $1.04 | $14.57M | 13.49M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 21024 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 241 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 21024 | 1.090 |
3 | 56689 | 1.085 |
3 | 179856 | 1.080 |
16 | 91048 | 1.075 |
2 | 22845 | 1.070 |
Price($) | Vol. | No. |
---|---|---|
1.095 | 241 | 1 |
1.100 | 271800 | 7 |
1.105 | 10740 | 2 |
1.110 | 147919 | 6 |
1.115 | 98426 | 5 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |